No one-size-fits-all solution to medicines shortages

Recommendations for the government to support the domestic production of HRT medicines are currently not feasible, Department says  Domestic manufacture of hormone replacement therapy (HRT) products is likely to be expensive and “effectively infeasible” a Senate Estimates hearing has been told.   Responding to questions about shortages of HRT medications and the potential for the